Questions? Call 888-624-8373

PAPERBACK
list:$36.75
Web:$33.08
add to cart

Rights & Permissions

Free PDF Access

topleft topright

Design Considerations for Evaluating the Impact of PEPFAR: Workshop Summary (2008)
Board on Global Health (BGH)

Page
34
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Design Considerations for Evaluating the Impact of PEPFAR: Workshop Summary

PHE is also developing tools to ensure quality and consistency of data, enhance the capability to aggregate results across different countries and different settings, and set priorities using a more open and systematic process.

EVALUATIVE APPROACH AND MAJOR FINDINGS OF THE IOM PEPFAR EVALUATION COMMITTEE

Speaker Jaime Sepúlveda of the University of California–San Francisco provided background on the work of the IOM expert committee appointed by Congress to conduct an evaluation of PEPFAR implementation. The committee, which Sepúlveda chaired, began work on the project early in its implementation because the evaluation of PEPFAR was mandated to be delivered 3 years after the legislation was passed. Because of the time frame, it was only possible to evaluate the first phase of the implementation. Sepúlveda summarized the major conclusions and recommendations from the committee’s report, PEPFAR Implementation: Progress and Promise (IOM, 2007) (see Box 1-2). Sepúlveda also offered the committee’s perspective on the design of impact measures for future evaluation of PEPFAR.

BOX 1-2

Main Recommendations from IOM Evaluation of PEPFAR

Address long-term factors

  • Emphasize prevention

  • Empower women

  • Build workforce capacity

  • Expand knowledge base

Improve harmonization

  • Improve coordination

  • Support the World Health Organization prequalification process

  • Remove budget allocations

Expand, improve, integrate services

  • Data-driven prevention

  • Adequate medications for treatment

  • Community-based, family-centered care

  • Target for orphans and vulnerable children

  • Attention to marginalized populations

Page
34